195 related articles for article (PubMed ID: 1374792)
1. Electrodermal orienting response and central nervous system dopamine and serotonin activity in schizophrenia.
Ohlund LS; Lindström LH; Ohman A
J Nerv Ment Dis; 1992 May; 180(5):304-13. PubMed ID: 1374792
[TBL] [Abstract][Full Text] [Related]
2. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
3. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
4. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
5. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
6. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
Massarotti M; Migliore A; Roccella P; Toffano G
Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
[No Abstract] [Full Text] [Related]
7. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
9. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
[No Abstract] [Full Text] [Related]
10. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
[No Abstract] [Full Text] [Related]
11. [Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics].
Jiang S; Chen X; Liao W
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):155-6. PubMed ID: 10681831
[TBL] [Abstract][Full Text] [Related]
12. Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients.
Lindström LH; Wieselgren IM; Klockhoff I; Svedberg A
Biol Psychiatry; 1990 Sep; 28(5):435-42. PubMed ID: 1698468
[TBL] [Abstract][Full Text] [Related]
13. Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
Bartfai A; Levander SE; Sedvall G
Biol Psychiatry; 1983 Sep; 18(9):971-87. PubMed ID: 6196060
[TBL] [Abstract][Full Text] [Related]
14. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
[TBL] [Abstract][Full Text] [Related]
15. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid amine metabolites in acute schizophrenia.
Post RM; Fink E; Carpenter WT; Goodwin FK
Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
Sedvall G
Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
[TBL] [Abstract][Full Text] [Related]
20. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
Nishijima K; Ishiguro T
Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
